The zebrafish is an important experimental system for vertebrate embryology, and is well suited to the molecular analysis of muscle development. Transcription factors, such as the MEF2s, regulate skeletal and cardiac muscle-specific genes during development. We report the identification of three zebrafish MEF2 genes which, like their mammalian counterparts, encode factors that function as DNAbinding transcriptional activators of muscle specific promoters. The pattern of MEF2 expression in zebrafish defines discrete cell populations in the developing somites and heart and has mechanistic implications for developmental regulation of the MEF2 genes, when compared with other species, Alteration of MEF2 expression in two mutants affecting somitogenesis provides insight into the control of muscle formation in the embryo.
Introduction
Patterning of the vertebrate embryo is mediated by cellular inductive interactions and by regulatory molecules that specify cell lineages, tissues and, ultimately, organs. Important paradigms for these processes have emerged from the study of cardiac and skeletal muscle formation. Inductive events between pharyngeal endoderm and the adjacent mesoderm are critical for cardiogenesis (Nascone and Mercola, 1995; Schultheiss and Lassar, 1995; and references therein) . Similarly, interactions between axial structures and the paraxial mesoderm affect somitogenesis and partitioning of the dermomyotome and sclerotome (Miinsterberg and Lassar, 1995; Fan and Tessier-Lavigne, 1995;  and references therein). Myogenie differentiation in both heart and somites is further understood to be governed by networks of cell-specific or cell-restricted regulatory factors that modulate the activity of their target genes (reviewed in Lassar and Miinster-'Current address: Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143-0554, USA.
* Corresponding author. e-mail: breitbart@phenix.tch.harvard.edu berg, 1995) . The pathways that link these molecular mechanisms to inductive events in the embryo are largely unknown, although the participation of diffusible factors has recently been established (Buffinger and Stockdale, 1995; Fan and Tessier-Lavigne, 1995) . Experimental models are needed in which these pathways can be dissected.
The zebrafish, Danio rerio, has emerged as a particularly tractable system for the study of vertebrate embryogenesis, principally because it is amenable to embryological manipulations and to molecular and genetic analyses (reviewed in Kimmel, 1989) . The embryos develop rapidly and remain completely transparent throughout much of organ formation. In addition to a number of spontaneously occurring mutations, hundreds of informative mutant phenotypes have been identified in large-scale mutagenesis screens of the zebrafish genome (Driever et al., 1994; Mullins and Niisslein-Volhard, 1995) . Many of these affect somite formation or cardiovascular development (Stainier and Fishman, 1994) . Furthermore, a number of studies have demonstrated that, in general, zebrafish cardiac and skeletal muscle development follow patterns typical of all vertebrates (reviewed in Fishman et al., 1996) . To date, however, few molecular myogenic factors have been elucidated in the fish (Weinberg et al., 1996) .. The identification and characterization of such molecules is critical to the analysis of somitogenesis and cardiogenesis in this organism.
Myocyte-specific enhancer factor 2 (MEF2), which binds an A/T-rich sequence required for the activation of many cardiac and skeletal muscle-specific promoters and enhancers, is a key regulator for both the cardiac and skeletal muscle lineages (Gossett et al., 1989; . Multiple MEF2s (also called RSRFs and SLs; see Breitbart et al., 1993 , for nomenclature) have been identified in the human (Pollock and Treisman, 1991; Fig. 1 . MEF2 sequences are highly conserved from zebrafish to human. The ammo acid sequences encoded by each cloned zebrafish MEF2 cDNA are shown. Comparisons of these sequences with their counterparts in the C&bank am diagrammed. In each case, the percent identity between zebrafish and human, mouse, or frog is indicated within boxes representing defined regions of these proteins; the residue numbers from the zebrafish sequences am indicated above each box. These regions include the MADS and MEF2 domains and the best-matched altemative'sequences identified in the human MEF2s: exons a and * in hMEF2A (Yu et al., 1992) ; exons A and B in hMEF2C (McDermott et al., 1993) ; and exons a' and b in hMEF2D (Breitbart et al., 1993) . Note that the percent identity between zebrafish and frog MEF2D residues 87-132, shown in parentheses, is low because the frog sequence in this region (SLl; Chambers et al., 1992) appears to be an alternative exon mom similar to hMEFQD exon a (Bmitbart et al., 1993 ; not shown). The percent identities in the region corresponding to hMEF2D exon b are also relatively low, but the substitutions am conservative and preserve the characteristic acidic nature of this short peptide (Yu et al., 1992; Breitbart et al.. 1993 Breitbart et al.. ). al., 1992 Leifer et al., 1992; McDermott et al., 1993; Breitbart et al., 1993) , mouse (Martin et al., 1993 (Martin et al., , 1994 , and frog (Chambers et al., 1992) , while a single D-m@2 gene has been found in Drosophila (Lilly et al., 1994; Nguyen et al., 1994) . All contain the DNA-binding protein domain characteristic of the MADS gene family (reviewed in Shore and Sharrocks, 1995) and an adjacent, highly conserved MEF2-specific domain.
MEF2 is a regulator of the myogenic bHLH genes, including myogenin (Edmondson et al., 1992; Yee and Rigby, 1993; Cheng et al., 1993; Buchberger et al., 1994) , myoD (Wong et al., 1994) , and rnyfi (MRF4; Black et al., 1995; Naidu et al., 1995) . In addition, MEF2 cooperates with these factors in activating skeletal muscle-specific transcription (Kaushal et al., 1994; Molkentin et al., 1995) . Ectopic expression of recombinant MEF2 activates cardiac-specific gene transcription in Xenopus animal caps (Chambers et al., 1994) ; whether it also induces myogenesis in cultured fibroblasts is controversial (Kaushal et al., 1994; Molkentin et al., 1995) . Furthermore, Drosophila mef2 loss-of-function mutants fail to develop differentiated somatic, visceral, and cardiac (i.e. dorsal vessel) muscle, confirming the critical importance of MEF2 activity in these lineages (Lilly et al., 1995; Bour et al., 1995) . Free ME Probe
Here we report the characterization of three zebrafish MEF2 factors which, like their mammalian counterparts, function as DNA-binding transcriptional activators of muscle-specific promoters. In the embryo, the initial appearance of these factors defines discrete cell populations in the developing somites and heart. The pattern of MEF2 expression in wild-type zebrafish, as compared with other species, has mechanistic implications for developmental regulation of the MEF2 genes. Alteration of MEF2 expression in two mutant phenotypes affecting somitogenesis provides insight into the control of muscle formation in the embryo.
Results

Three zebrafish MEF2 genes encode sequencespecific DNA-binding transcription factors
Using a probe comprising the conserved MADS/MEF2 fragment of the human MEF2B cDNA (Yu et al., 1992) , we isolated cDNA clones containing complete coding sequences for zebrafish MEF2A, MEF2C, and MEF2D, products of three distinct genes ( Fig. 1 (Yu et al., 1992) , in the absence (-) of competitor. Binding was specifically competed by a 50-fold molar excess of competitor oligonucleotide 4. which retains consensus MEF2 binding sequences, but not by competitor 6. in which they are mutated (MEF2mt4 and MEF2mt6; Csejesi and Olson, 1991; Yu et al., 1992) . Control extract was prepared from mock-transfected COS cells. It is not known whether the greater relative intensity of the shifted bands for MEF2D reflects a real difference in binding affinity or, instead. more abundant expression of this protein compared to the others. (B) CAT assays, normalized for transfection efficiency, demonstrate that each zebrafish MEF2, like human MEF2A (hMEF2A), activated expression of a MEF2-dependent reporter construct with intact MEF2 binding sites (WT Reporter), but not that with mutated sites (MUT Reporter; pE102MEF2x2 and pEl02MEF2x2mut. respectively; Yu et al.. 1992) . Control cells were transfected with zebrafish MEFZC in the antisense orientation.
counterparts in other vertebrates, with virtually complete conservation of amino acid sequence within the MADS (aa 3-57) and MEF2 (aa 58-86) domains. Furthermore, each is more similar to its respective human counterpart than to the other zebrafish MEF2s. Certain sequences known to be alternatively spliced in human MEF2A, MEF2C, and MEF2D are present in these cDNAs, whereas others are absent. This is consistent with possible alternative splicing in the fish but was not investigated further here.
The marked phylogenetic sequence conservation suggested that the zebrafish MEF2s would function as DNAbinding activators of transcription. To test this, recombinant zebrafish MEF2A, MEF2C, and MEF2D proteins were individually expressed in COS cells, which lack endogenous MEF2 activity (Yu et al., 1992) by transfection of appropriate cDNA vectors. Nuclear extracts from these cells bound a double-stranded oligonucleotide probe containing the MEF2 site from the muscle creatine kinase enhancer in a gel shift assay ( Fig. 2A ). Zebrafish MEF2 binding was sequence-specific because it was efficiently competed by a mutant oligonucleotide in which a consensus MEF2 site is preserved (MEF2mt4), but not by another mutant in which the consensus is abolished (MEF2mt6; Cserjesi and Olson, 1991; Yu et al., 1992) . When cotransfected with a reporter gene that requires MEF2 in rruns for activity (Yu et al., 1992) each of the zebrafish factors produced marked (6-30-fold) transcriptional activation, comparable to that for human MEF2, that was dependent on the presence of intact MEF2 binding sites in the reporter gene (Fig. 2B ). These data show that, like Drosophila MEF2 (Lilly et al., 1994; Nguyen et al., 1994) , the zebrafish MEF2s have the same sequence specificity as their mammalian counterparts within the limits of the assays, and function as bona fide transcriptional activators even in the context of mammalian cells. Further experiments to define optimal DNA binding sites for these proteins are beyond the scope of this study.
The MEF2s are early markers of zebrafish somitogenesis
We examined the expression patterns of the three MEF2 genes in early zebrafish development by in situ hybridization using gene-specific antisense RNA probes. Through 48 hours post-fertilization (hpf) by which time most organogenesis is complete, MEF2 expression was largely specific to cells of the somitic and cardiac lineages (it was also detected in brain, and at later stages in intestinal smooth muscle, which are outside the scope of this study). mef2D transcripts are the first to be detected, appearing at 8.5 hpf in mid-gastrulation in two clusters of cells on either side of the elongating embryonic shield (not shown). By 10-l 1 hpf, when the first somite furrow appears, mej2D transcripts are present in two cords of adaxial cells running parallet and immediately adjacent to the extending notochord rudiment in the presomitic mesoderm (Figs. 3A and C). Over time these cords broaden to include more lateral paraxial cells at some distance from the notochord (compare Figs. 3C and 4B; additional data not shown). At 14 hpf (10 somites), mef2D transcripts appear in cells that form discrete lateral extensions within the first 5-7 somite pairs simultaneously, while expression in the more caudal mesoderm remains confined to the paraxial cells. It is also at this stage that the morphologically distinct muscle pioneer cells appear, also simultaneously, in these most rostra1 somites (Felsenfeld et al., 1991) . Similar lateral extension of meJ2D expression occurs in subsequent somite pairs in a rostro-caudal progression as they mature (Fig. 3B) , and the myotomes acquire their characteristic chevron shape, pointing rostrally (Fig. 4G) . Here, me@D-expressing cells occupy the anterior and posterior boundaries of each compartment, clustering along both sides of the transverse myoseptum that divides successive myotomes. More centrally located cells show no mej2D expression (see also below, and Fig. 4H ).
meftA and mej2C transcripts appear later than those of mej2D but recapitulate the same positional pattern, beginning in the adaxial cells and progressing in the developing somites (not shown). mej2A transcripts first appear at approximately 10 hpf, and by 12 hpf their distribution is indistinguishable from those of mej2D. The first appearance of zebrafish myogenin transcripts is approximately coincident with that of meJZA (Weinberg et al., 1996; Ticho and Breitbart, unpublished observations). mejX transcripts first appear at 12 hpf, and by 16 hpf, the pattern for all three MEF2 genes is essentially identical. All are also detected in the fin bud musculature by 48 hpf (not shown).
A number of studies have found that MEF2 protein is not present in all cells that contain MEF2 mRNA, suggesting a role for translational regulation of MEF2 expression (Yu et al., 1992; McDermott et al., 1993; Breit- Suzuki et al., 1995) . To address possible translational MEF2 regulation in early development, we examined the distribution of MEF2 protein by immunohistochemistry on sectioned zebrafish embryos, using the anti-MEF2D(A) antiserum that detects MEF2D but crossreacts weakly with MEF2A (see Section 4). MEF2 proteins appear by 11 hpf in the nuclei of the adaxial cells in the newly forming rostral-most somites, adjacent to the notochord (Fig. 3D) . mRNA encoding MEF2D has been present for approximately 2 h in these cells, whereas that for MEF2A is just appearing at this stage (see above); thus, the first detected protein is likely to be MEF2D. As development proceeds, MEF%D, MEF2A, or both are expressed abundantly in the myotomes (Fig. 4H) . Cells expressing these proteins cluster peripherally along the transverse myoseptum in each chevron-shaped myotome in precisely the same pattern revealed by the corresponding mRNAs (Fig. 4H) , and form dorsal and ventral axial muscle groups (Fig. 4C ).
EssentiaIly the same patterns were observed at 20 and 24 hpf using antisera against zebrafish MEF2A and MEF2C, both of which cross-react with MEF2D (anti-MEF2A(D) and anti-MEF2C(D); not shown). We found no evidence that any population of myogenic cells in the early embryo accumulates MEF2 mRNA without ultimately expressing MEF2 protein. This tends to negate a significant role for translational regulation of MEF2 expression during somitogenesis, but this cannot be conclusively demonstrated in the absence of antibodies that are truly specific for each of the MEF2s. These experiments also demonstrate that MEF2 proteins are strictly nuclear in vivo, consistent with their function as transcription factors, and that differentiated zebrafish skeletal muscle cells remain mononuclear at least through 24 hpf (Figs. 4C and H, and data not shown; Waterman, 1969; Kimmel and Warga, 1987) .
Abnormal patterns of MEF2 expression characterize two zebrafish mutants with abnormal somitogenesis
Having established the normal patterns of zebrafish MEF2 expression in early skeletal muscle formation, we sought to determine how these patterns might be altered in floating head (flh) and spadetail (spt) mutants, both of which have defective somitogenesis. flh is the zebrafish homolog of the XhJot homeobox gene, and several mutant alleles have been identified (Talbot et al., 1995) . The homozygous null flh phenotype is characterized by the absence of a differentiated notochord and more ventral midline structures including the hypochord, dorsal aorta, and cardinal vein. In their place, the somites and ultimately the myotomes are fused across the midline (Talbot et al., 1995) . The onset of meflD transcription in the unsegmented paraxial mesoderm offlh"""' embryos is temporally normal but extends abnormally across the midline, occupying the compartments under the neural keel that normally contain the forming notochord and ventral midline structures (compare Figs. 3A and 3E, 3C and 3G) . This midline expression is initially diffuse but then appears more consolidated into discrete 'bridges' of cells that may anticipate the segmentation that will occur with somite formation (compare Figs. 3B and 3F ). mef2A and mef2C expression patterns are also temporally normal but similarly abnormal in position in flh"1"21 (not shown). Cells first expressing MEF2 protein, normally arrayed near the notochord in the wild-type, appear in jlhnl/nl to be dispersed randomly throughout the fused somites (compare Figs. 3D and 3H ). Thus theflh gene is not required for initiation of MEF2 expression but, in the absence of the normal notochord, the organization of MEFZexpressing cells is disrupted.
Homozygous spt mutants have an enlarged and tortuous notochord and fail to develop normal trunk somites, while head and tail structures are largely preserved (Kimmel et al., 1989) . This phenotype is known to arise, at least in part, because mesodermal precursor cells normally destined for the trunk migrate instead into the tail during gastrulation. Several allelic spt strains have been obtained, but the gene has not yet been identified (Kimmel et al., 1989; Ho and Kane, 1990) . The onset of mef2D expression is delayed by approximately eight hours in ~pfi'~'" mutant embryos and appears sporadically in a few scattered clusters of cells in the trunk mesoderm, in marked contradistinction to the normal pattern (compare Figs. 4A and 4D ). These clusters are generally unpaired, and their number and position in the rostral-caudal axis differ from embryo to embryo; furthermore, they may be either close to or distant from the abnormal notochord (compare Figs. 4B and 4E, 4C and 4F, and 4H and 41) . The expression of mef2D transcripts in the tail, in contrast, is both temporally and positionally correct and appears limited to the normal paraxial mesoderm, i.e. there is no ectopic mef2D expression in the abnormal cell mass of the tail (not shown). The truncal expression of mq%A and me$?C in spt mutants is similarly delayed and spatially disrupted (not shown). Thus it may be inferred that the normal spt gene is required, directly or indirectly, for timely initiation of MEF2 expression as well as for the correct positional fates of MEF2-expressing cells.
Zebra&h MEF2s are early markers of the myocardial cell lineage
While mef2D is the first zebrafish MEF2 gene expressed in the presomitic mesoderm, mej2C is first in cells that give rise to the heart. mejX transcripts are detected faintly beginning at 16 hpf (14 somites) in cells of the paired cardiac primordia, which at this stage are located ventrally beneath the hindbrain, in close apposition to the yolk ( Fig. 5A ; mej2C transcripts are in very low abundance at this earliest stage and, therefore, are barely detectable above background.) These cells also express the zebrafish homeobox genes nkx2.5 and nkr2.7, also early markers of the myocardial cell lineage (Lee et al., 1996) . More robust mefZC expression is evident by 18 hpf in the cardiac primordia as they appear to fuse first caudally and then rostrally to form a ring of presumptive myocardium (Figs. 5B and 5C ). The ring encircles cells not expressing mej2C that are thought to comprise the portion moyenne that gives rise to the endocardium (Senior, 1909; Stainier et al., 1993) . Cardiac meflA transcripts also appear at this time and co-localize with those of mefZC and afropomyosin, marking myocardial differentiation (not shown). me@C and mejI?A continue to be expressed in the heart at least through 48 hpf (not shown). However, no mef2D transcripts could be detected during these stages of zebrafish cardiogenesis, despite exhaustive in situ hybridization assays with a range of probes and techniques; our data do not exclude possible cardiac meflD expression after 48 hpf.
Discrete myocardial and endocardial cell layers can be resolved in the fused zebrafish heart tube. Using the anti-MEFZD(A) antiserum, nuclear MEF2 protein was detected specifically in cells of the single-layer myocardium both in the atrium and ventricle, while none appeared in the endocardium (Fig. 5D and 5E ). This protein is presumably MEF2A, since no MEF2D mRNA appears in the heart through this stage. Identical immunostaining was also obtained with anti-MEF2A(D) and anti-MEF2C(D), detecting MEF2A and MEF2C proteins, respectively (not shown). We also examined MEF2 expression in the hearts of homozygous jlh"' mutants which by 48 hpf appear dilated and weakly contractile (not shown), possibly secondary to the deficient vascular bed in these embryos (Talbot et al., 1995) . Immunostained sections show that both atrium and ventricle are dilated, and the ventricular wall thinned, while MEF2-expressing cells appear relatively normal in number (compare Figs. 5E and 5F).
Discussion
I. Zebrafish MEF2s are the products of three highly conserved vertebrate genes
Three zebrafish MEF2s have been cloned and identified based on homology to previously identified human factors. The marked evolutionary conservation within the MADS and MEF2 domains of these proteins speaks to their importance in MEF2 function, as previously noted (Chambers et al., 1992 , Lilly et al., 1994 Nguyen et al., 1994) . Outside these regions, the conservation is less complete, but nonetheless sufficient between the zebrafish factors and their respective human counterparts to permit their unambiguous assignment as MEF2A, MEF2C, and MEF2D. No zebrafish ortholog of MEF2B (RSRFR2; Pollock and Treisman, 1991; Yu et al., 1992 , Molkentin et al., 1996 was identified in this study, despite the fact that the human MEF2B sequence was used as the probe for the screen. In theory, a zebrafish MEF2B might be expressed at other developmental stages and, hence, not represented in the cDNA library screened here; however, the presence of a fourth zebrafish MEF2 gene was also not indicated in low-stringency genomic Southern blots using the MEF2B probe (not shown), nor has a MEF2B ortholog been reported in the frog.
The functional conservation among the zebrafish MEF2s is complete to the extent that each is able to activate transcription via sequence-specific DNA binding to the MEF2 site. In fact, the activities of the recombinant zebrafish factors are comparable to those observed for human MEF2 in the context of transfected mammalian cells; thus, like the single Drosophila MEF2 (Nguyen et al., 1994) zebrafish MEF2A, MEF2C, and MEF2D must have phylogenetically conserved domains for proper nu-clear localization and for functional interaction with the general transcriptional machinery in these cells. These domains remain to be defined.
Temporal activation of MEF2 gene expression is species-specific
The onset of transcription of the three MEF2 genes in the early zebrafish embryo occurs in a discrete temporal order (Fig. 6 ). In the presomitic mesoderm, meflD is activated first, followed at approximately two hour intervals by mef2A and then me$?C. In the early cardiac lineage, m&C expression precedes mej2A, and no meflD transcripts are detected. These patterns of activation are different than those found in other vertebrate species. In Xenopus, mef2D (SLl) precedes m&A (SL2) in both somites and heart (Chambers et al., 1992; . In the mouse, meflC transcripts appear first in both the skeletal and cardiac muscle lineages, followed by mej2A and mej2D; and low-level expression of mefZD is found outside these lineages (Edmondson et al., 1994) . Thus, despite the extensive structural and functional conservation of these genes among vertebrates, their transcriptional regulation in early development is divergent, both in terms of timing and tissue restriction. The duplications that gave rise to mej2A, meJ?C, and me@D must have preceded the evolutionary radiation of fish and mammals. However, the different regulatory programs that specify the activation of these genes would appear to have evolved later. Such species-specific differences in tempoSmite No. 1 ral patterns of activation also occur in the myogenic bHLH family of muscle transcription factors (Pownall and Emerson, 1992; reviewed in Lassar and Miinsterberg, 1995) , which in this regard serves as a paradigm for the MEF2 family.
Role of MEF2 in zebrafish somitogenesis
The identification and characterization of three zebrafish MEF2s is an important step in the broader investigation of normal and abnormal muscle development. It is likely that MEF2 plays a critically important role in myogenesis in the fish as it does in Drosophila (Lilly et al., 1995; Bour et al., 1995) , and as it is presumed to play in tetrapods. Zebrafish MEF2 is expressed initially in the paraxial cells of the presomitic mesoderm, shortly after the expression in these same cells of myoD (Weinberg et al., 1996; Ticho and Breitbart, unpublished observations) and, before that, snail1 (Hammerschmidt and NiissleinVolhard, 1993; Thisse et al., 1993) . It is likely but as yet unproved that the expression of MEF2 in the skeletal muscle lineage is activated by a cascade of genes, including snail1 and myoD, that must specify mesodermal cell fates in the zebrafish. Furthermore, coincident expression of the mef2 genes and myoD is consistent with their cooperative activity in the induction of muscle-specific transcription (Kaushal et al., 1994; Molkentin et al., 1995) .
Comparison of zebrafish MEF2 expression in the wildtype with spadetail and floating head mutants provides information about developmental mechanisms that regu- late the MEF2 genes. In the wild-type, the earliest expression of MEFZ is detected in those cells immediately adjacent to the rudimentary notochord, raising the possibility that the notochord might participate in the activation of MEF2 expression. A role for notochord in the induction of skeletal muscle in the zebrafish is strongly supported by experiments in which defective somitogenesis in no tail mutants, which lack a definitive notochord, is rescued by transplantation of wild-type notochord cells (Halpern et al., 1993) . In the chick, several studies support a similar inductive role for the notochord, either alone or in combination with floorplate (Rong et al., 1992; Buffinger and Stockdale, 1994; Stern and Hauschka, 1995; Mtinsterberg and Lassar, 1995) . Other studies suggest that notochord may induce more ventral, non-myotomal cell fates (Pourquit et al., 1993; Bober et al., 1994; Fan and Tessier-Lavigne, 1994) . The pattern of MEF2 expression in spt mutants, in cells both near to and distant from the notochord, would indicate that physical proximity to the notochord is not an essential feature of MEF2 induction. The origin of these inconstant clusters of MEFZexpressing cells, however, is unknown. They might arise from occasional trunk mesodermal precursors that stochastically undergo relatively normal migration despite the spt mutation, or they may be trans-fated from other lineages. The very late onset of MEF2 expression in these cells favors the latter hypothesis. The findings obtained here for the MEF2 genes in spt are similar to those recently reported for myoD (Weinberg et al., 1996) . The analysis of MEF2 gene expression in theflh phenotype indicates that transcription of these genes begins at the normal times in the paraxial mesoderm, but that ectopic expression also develops axially in cells positioned where the notochord and ventral midline structures would normally lie. Indeed, the appearance of mef2D transcripts in these cells as early as 8.5 hpf indicates that they become myogenic even earlier than originally reported (Talbot et al., 1995) . Cell transplantation experiments have shown that these flh-cells assume their myogenic fate autonomously, and also express myoD (Halpern et al., 1995) . Although these axial cells appear to manifest much if not all of the early skeletal muscle program and become segmentally arranged in the anterior-posterior axis, MEF2 immunostaining shows that they fail to form the ordered arrays found in normal somites. Thus, theflh gene is not required for temporally normal initiation of MEF2 expression but, in the absence of notochord, the organization of MEFZ-expressing cells is disrupted.
The findings reported here also reveal differences in the molecular determinants of somitogenesis between zebrafish and higher vertebrates. The initial expression of MEF2 in mouse skeletal muscle occurs in discrete myotomes within well-defined somites (Edmondson et al., 1994) ; that in zebrafish occurs at a relatively earlier stage, before somites are formed: In fact, at the molecular level, skeletal myogenesis in the fish (and the frog; see Lassar and Miinsterberg, 1995) is more accelerated in general than it is in mammals. Zebrafish myogenin and & tropomyosin transcripts, markers of the differentiated muscle phenotype in mammals, also accumulate in the adaxial cells before somites are formed (Weinberg et al., 1996; Ticho and Breitbart, unpublished observations) . A subset of these cells gives rise to morphologically distinct muscle pioneer cells that are the first to express the differentiated muscle phenotype in the zebrafish (Felsenfeld et al., 1991) . Whether or not these events reflect a fundamental difference in the way skeletal muscle tissues become organized in teleosts versus mammals is unknown.
Role of A4EF2 in zebrafish cardiogenesis
Our understanding of the molecular determinants of cardiac muscle development lags behind that for skeletal muscle. The findings reported here demonstrate that me$?C, expressed in the bilateral cardiac primordia, is among the earliest markers of cells that give rise to the heart in the zebra&h, as it is in the mouse (Edmondson et al., 1994) . Several other key cardiac transcription factor genes, including the zinc finger factor GATA4 (Kelley et al., 1993; Heikinheimo et al., 1994; L. Zen, pers. commun.) , the bHLH factor dHAND and eHAND (Srivastava et al., 1995) and two homologs of the homeobox factor Csx/Nkx-2.5 (Komuro and Izumo, 1993; Lints et al., 1993; Lee et al., 1996) , are expressed at nearly the same time as mej2C in the zebrafish (Ticho and Breitbart, unpublished observations). The possibility of crossregulation or functional interactions among these various transcription factors in the heart is, at present, a matter of conjecture. Cardiac expression of zebrafish mej2A begins somewhat later, at the time of phenotypic myocardial differentiation. Curiously, no meflD transcripts were detected in the early zebrafish heart, in contrast to findings in Xenopus and the mouse (Chambers et al., 1992 (Chambers et al., , 1994 Edmondson et al., 1994 ; our data do not exclude the possible expression of mef2D at later stages). In experiments in Xenopus, MEF2D (SLl) but not MEF2A (SL2) was capable of inducing cardiac-specific gene transcription in animal caps (Chambers et al., 1994) . The absence of MEF2D in the early zebrafish heart, however, would indicate that in the fish such induction is supported instead by MEF2C and MEF2A.
Species-specific differences in the expression of the MEF2s, both in somites and heart, beg the question as to whether these factors might be functionally interchangeable in the vertebrate embryo; whether, for example, MEF2C might substitute effectively for MEF2D if expressed at the appropriate time. In contrast, the strong evolutionary conservation of three different MEF2 genes from zebrafish to human argues that their functions are distinct rather than redundant. Reconciliation of these disparate hypotheses will require further study.
Experimental procedures
Fish stocks
Zebrafish, either AB strain (Massachusetts General Hospital stocks) or wild-type (Ekkwill, Tampa, FL), were raised, handled, and staged according to standard methods (Westerfield, 1995) . jlh+/"' and spP'06 embryos were obtained from the Institute of Neuroscience, University of Oregon. Phenotypically homozygous embryos were obtained at a rate of approximately 25% from crosses between the respective adult heterozygotes for each mutant.
cDNA cloning and sequencing
The 233 bp BglII-XhoI fragment of the human MEF2B cDNA (Yu et al., 1992) , comprising most of the MADS and MEF2 domain sequences, was used as a probe to screen IO6 recombinants from a 30-36 hpf whole zebrafish embryo Agt-11 cDNA library (gift of K. Zinn) at low stringency (hybridization in 25% formamide15x SSC/Sx Denhardt's125 mM Na phosphate, pH 6.5/0.1% SDS/O.25 mg/ml calf thymus DNA, at 37°C; wash in 2x SSC/O.2% SDS, at 37°C). Twenty-four positive clones were isolated, comprising three groups corresponding to MEF2A, MEF;?C, and MEF2D. The longest cDNA for each (MEF2A, 2.1 kb; MEF2C, 3.7 kb; MEF2D, 2.0 kb) was subcloned into pBluescript II (Stratagene, La Jolla, CA) and completely sequenced according to previously described methods (Yu et al., 1992) .
Cell transfection and gel shif assays
Subcloning of cDNAs into the pMT2 eukaryotic expression vector (Kaufman et al., 1989 ) COS cell transfection, nuclear extract preparation, gel shift analysis, cotransfection with MEF2-dependent and mutant chloramphenicol acetyl transferase (CAT) reporter constructs, and normalized CAT assays were all performed as described previously (Yu et al., 1992; Breitbart et al., 1993) .
in situ hybridization
Antisense RNA probes and sense controls were synthesized from truncated cDNA plasmids and partially hydrolyzed, as described by Harland (1991) . The most gene-specific regions were used in each case: the MEF2A probe comprised 765 nt of C-terminal coding sequence and the contiguous 270 nt of 3'-untranslated sequences; the MEF2C probe comprised 330 nt of C-terminal coding sequence and the contiguous 60 nt of 3'-untranslated sequence; the MEF2D probe comprised 744 nt of Cterminal coding sequence and the contiguous 65 nt of 3'-untranslated sequence. A full-length MEF2D probe was also used in additional attempts to detect mej2D transcripts in the heart. Each of these probes appeared to detect only its cognate mRNA according to the following observations: the MEF2A probe did not detect messages prior to 10 hpf, although MEF2D messages are present earlier, similarly the MEF2C probe did not detect messages prior to 12 hpf. The MEF2D probe produced no signal in the heart despite the presence of cardiac MEF2A and C transcripts.
Whole-mount in situ hybridization was performed according to Harland (1991) , with the following modifications. Staged embryos were fixed in 0.1 M MOPS, pH 7.412 mM EGTA/l mM MgS04/3.7% formaldehyde at room temperature for 2 h or at 4°C overnight, manually dechorionated, transferred to methanol, and stored at -20°C until used. After rehydration, embryos were digested with proteinase K, lOpg/ml, for varying times based on developmental stage: 10 min for 8-10 h postfertilization (hpf), 15 min for 11-16 hpf, 18 min for 17-20 hpf, 25 min for 22-24 hpf, and 30 min for older embryos. Following hybridization and washing with 0.2~ SSC/O.3% CHAPS, the embryos were transferred directly into PBS containing 2 mg/ml BSA and 0.1% Triton X-100. After staining, embryos were fixed in 4% formaldehyde and stored in methanol at -20°C.
For sections, in situ-stained whole-mount embryos were embedded in JB-4 medium (Polysciences, Inc., Warrington, PA) and sectioned serially at a thickness of 6-8 pm, and mounted in Permount (Fisher Scientific, Fair Lawn, NJ).
Whole-mount and sectioned embryos were viewed and photographed on a Zeiss Axiophot microscope, using Nomarski optics.
Immunochemistry
Rabbit polyclonal antisera were raised (HRP, Denver, PA) against the least-conserved C-terminal domains of each of the zebrafish MEF2 proteins: MEF2A, aa 317-460; MEF2C, aa 103-449; and MEF2D, aa 282-529. These were expressed in the pGEX3X vector (Pharmacia Biotech, Piscataway, NJ) as bacterial fusion proteins with glutathione-S-transferase and purified on glutathionesepharose and SDS-PAGE prior to injection (two animals per antigen). The resulting antisera were tested for titer and specificity on Western blots that included the fusion proteins and the full-length MEF2 proteins extracted from cDNA-transfected COS cells (see above), but all crossreacted weakly with a non-cognate MEF2 (not shown). Thus, the MEF2A antigen yielded anti-MEF2A(D) antiserum that cross-reacted with zebrafish MEF2D; MEF2C yielded anti-MEF2C(D) that also cross-reacted with MEF2D; and MEF2D yielded anti-MEF2D(A) that crossreacted with MEF2A. This weak cross-reactivity persisted at detectable levels even after affinity purification on antigen-glutathione-sepharose and pre-adsorption with the cross-reacting antigen (Harlow and Lane, 1988) . Multiple other antisera raised against human MEF2A (Kaushal et al., 1994; Santa Cruz Biotechnology, CA), human MEF2C (Leifer et al., 1992) , and human MEF2D (Breitbart et al., 1993 ) also cross-reacted with more than one zebrafish MEF2. In all cases, putative epitopes common to two or more MEF2s could be identified in the fusion protein and synthetic peptide antigens, owing to the strong homologies among these proteins even outside the MADS and MEF2 domains. Therefore, antibodies exclusively recognizing each zebrafish MEF2 were not obtained.
For immunohistochemistry, staged embryos were fixed in 4% formaldehyde, dechorionated and stored in methanol at -20°C until used. They were dehydrated through a gradation of ethanol up to lOO%, incubated in xylene twice for 10 min, and then embedded in paraffin. Slides of serial 5 pm sections were heated to 60°C for 2 h and then stored until used. Prior to immunostaining, slides were treated with xylene twice for 10 min, rehydrated through a gradation of ethanol to PBS, incubated 20 min in methanol/3% hydrogen peroxide 5: 1, and then washed twice with PBS. The sections were blocked for 1 h in PBS/l% BSA/20% lamb serum (PBL), incubated overnight at 4°C in affinity-purified anti-MEF2 antibody diluted in PBL, washed 5 times in PBS, incubated l-2 h in peroxidase-conjugated goat anti-rabbit IgG (Boehringer Mannheim, Indianapolis, IN) diluted 1:200 in PBL, washed 5 times in PBS, stained with DAB peroxidase substrate (Vector, Burlingame, CA), rinsed with PBS, dehydrated into 100% ethanol, incubated with xylene twice for 10 min, and mounted with Permount.
